Elizabeth S. Yeh
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
78
Citations
8,587
Est. group size
—
Recurring co-author estimate
Active years
29
Publishing since 1998
Elizabeth S. Yeh studies the molecular biology of breast cancer, with a focus on the signaling enzyme HUNK (a kinase) and how it drives tumor growth, spread (metastasis), and resistance to therapy, particularly in HER2-positive and triple-negative breast cancers. Her work includes developing drug-like inhibitors targeting these pathways and examining processes such as autophagy (cellular self-recycling) and immune cells within tumors. She also publishes on pharmacology education and inclusive teaching practices.
Publication activity has been relatively steady over the past five years, averaging about five papers per year, following a peak in 2019.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Introducing a Professional Development Skill Building Platform Into a Biomedical Sciences Graduate Program Curriculum in Pharmacology
Pharmacology Research & Perspectives · 2025
- Modulating hormonally upregulated neu-associated kinase (HUNK) activity in breast cancer: The development of HUNK inhibitors
Journal of Pharmacology and Experimental Therapeutics · 2025
- Inhibitory Effects of Alpha-Connexin Carboxyl-Terminal Peptide on Canine Mammary Epithelial Cells: A Study on Benign and Malignant Phenotypes
Cancers · 2024
- Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Oncogene · 2024
- Special section on Breaking Barriers in Women's Cancer Treatment: Innovative Approaches and Experimental Therapeutics—Editorial
Journal of Pharmacology and Experimental Therapeutics · 2024
- Special Issue: Cancer Metastasis and Therapeutic Resistance
Biomedicines · 2023
- Development and Implementation of Equitable and Inclusive Teaching Practices in Pharmacology
Journal of Pharmacology and Experimental Therapeutics · 2023
- Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast Cancer
Frontiers in Immunology · 2022
- HUNK Regulation of Interleukin 4 in Triple Negative Breast Cancer
The FASEB Journal · 2022
- Abstract P5-07-02: Potential differences in stromal patterns from breast cancer metastatic lymph between South Carolina sea islander black women and white women
Cancer Research · 2022
- HUNK Phosphorylates Rubicon to Support Autophagy, Promoting Tumorigenesis in HER2+ Breast Cancer
The FASEB Journal · 2022
- Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells
Frontiers in Veterinary Science · 2021
- Correction: HUNK phosphorylates EGFR to regulate breast cancer metastasis
Oncogene · 2021
- HER2-Positive (HER2 +) Breast Cancer
Elsevier eBooks · 2021
- 680 Isoforms of neuropilin-2 regulate distinct macrophage functions and are associated with unique tumor-associated macrophages in murine and human breast cancer
Regular and Young Investigator Award Abstracts · 2021
- Journal of Pharmacology and Experimental Therapeutics×5
- Oncogene×4
- Biomedicines×4
- International Journal of Molecular Sciences×3
- Elsevier eBooks×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile